Our present study validates for the first time overexpression of GPM6B, MAGEA12 and FCRL1 in HCC patients relative to normal tissue and investigates DNA methylation within their promoters as a potential diagnostic marker of liver cancer. The gene discussed is FCRL1; the disease is hepatocellular carcinoma.